Developer docs
API playgroundTry for free, no card

Search company profiles

Univo IRB

Full company profile

uuid02lixrd

Namestring
Univo IRB
Legal namestring
Univo LLC
Websiteurl
univo-group.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Univo IRB is a U.S.-based central Institutional Review Board (IRB) provider offering independent ethics review and oversight for clinical research studies spanning Phase I-IV biomedical, biotech, medical device, and noninterventional trials. Founded in 2016 as Principal IRB, rebranded in February 2024, and acquired by healthcare-focused private equity firm QHP Capital in 2023, the company is headquartered in Raleigh, North Carolina, and operates primarily across North America, having launched Canadian Research Ethics Board (REB) review services in September 2024. Univo sells centralized study review services to sponsors, contract research organizations (CROs), academic medical centers, hospitals, research sites, and individual investigators under a quote-based professional-services model with multi-year contract support.

The company's core product is OneVerse®, a proprietary purpose-built electronic IRB submission portal that combines electronic submissions, real-time status tracking, dynamic form generation, document collaboration, and—since September 2025—AI-powered workflow automation covering process automation, predictive review-timeline forecasting, and knowledge retrieval. Adjacent revenue streams include Institutional Biosafety Committee (IBC) services, Human Research Protection (HRP) and Good Clinical Practice (GCP) training, and clinical research consulting on AI governance, auditing, study design, and voice-of-patient services. Pricing is not publicly disclosed; customers engage Univo through dedicated IRB professionals supplemented by the OneVerse self-serve portal and direct sales motion.

Univo differentiates through AAHRPP accreditation (held since 2020, reaccredited for five years in September 2023), FDA registration (IORG0009156 / IRB00010912) with a January 2026 inspection completed with zero findings, a leadership team composed of veterans from Independent IRB, Schulman, and Advarra, and strategic alliances with Validcare (June 2026, integrated CRO+IRB platform for emerging biotech) and The Patient View (January 2026, patient-insight analytics). Distribution relies on direct enterprise sales, industry-conference presence (SCOPE, ADLM, PRIM&R, ClinOps at Sea, SCRS Global), and a content-and-podcast-driven thought-leadership channel.

Short descriptiontext

Univo IRB provides independent central ethics review and oversight for clinical research, serving pharmaceutical sponsors, CROs, academic medical centers, research sites, and individual investigators via its proprietary AI-enabled OneVerse platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
institutional review board, ethics review services, clinical research oversight, biosafety committee review, human research protection
Industry2 codes
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)
NAICS code2 codes
  • Other Scientific and Technical Consulting Services54169
  • Educational Support Services611710
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Institutional Review Board Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1IRB Review Services
TypeProfessional Services
Description

Core revenue from providing independent ethics review and oversight for clinical research including Phase I-IV biomedical, biotech, medical device, and noninterventional studies. Revenue is generated through study review fees, with dedicated professionals assigned to each client.

univo-group.com
2Institutional Biosafety Committee (IBC) Services
TypeProfessional Services
Description

Support services for institutional biosafety committee approval as part of comprehensive regulatory oversight.

univo-group.com
3Training Services
TypeProfessional Services
Description

Human research protection (HRP) and good clinical practice (GCP) training services for research teams, administrators, and compliance staff. Includes accredited and certified training modules.

univo-group.com
4Clinical Research Consulting
TypeProfessional Services
Description

Consulting services including strategic guidance for research administration, AI governance, auditing and compliance, research study design, temporary staffing solutions, and voice of patient services.

univo-group.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing - contact for fee schedule
ModelOtherBilling cadenceMulti-year contract
Notes

Univo IRB does not publicly disclose pricing. The company states 'reasonable pricing' as one of their core values (Fair). Potential clients are directed to contact the team directly for fee schedules.

univo-group.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1OneVerse
Description

AI-enabled, purpose-built electronic IRB submission portal and platform for central IRB review, enabling study submission, secure document sharing, and direct communication across research study stakeholders.

univo-group.com
Core offering1 text field

Univo IRB provides independent Institutional Review Board (IRB) ethics review and oversight services for clinical research, covering Phase I-IV biomedical, biotech, medical device, and noninterventional studies. Core service delivery is supported by OneVerse®, a proprietary AI-enabled electronic IRB submission and workflow platform. Surrounding the platform, Univo IRB offers Institutional Biosafety Committee (IBC) approval support, Human Research Protection (HRP) and Good Clinical Practice (GCP) training, and clinical research consulting including AI governance, auditing, staffing, and patient insight services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 60% reduction in average turnaround times reported by early adopters
+4 more records
Product overview1 text field

Univo IRB operates as a next-generation Institutional Review Board provider offering a unified portfolio centered on its proprietary OneVerse® technology platform. OneVerse serves as the core electronic IRB platform enabling AI-powered workflow automation, electronic submissions, and real-time collaboration. Surrounding this platform, Univo provides complementary service modules including IRB Review Services (Phase I-IV biomedical, device, and behavioral research), IBC Services for biosafety committee approval, Training Services (HRP/GCP certification), and Clinical Research Consulting Services (strategic guidance, AI governance, auditing, and voice-of-patient support). The company emphasizes an integrated approach where technology and human expertise combine to deliver agile, patient-centered ethics review.

Product and service3 records
1OneVerse® Platform
CategoryIRB Technology Platform
Description

Proprietary purpose-built electronic IRB platform that modernizes IRB submission, review, and oversight. OneVerse provides AI-powered workflow automation, dynamic form generation, searchable submission tracking, live chat support, 24/7 access to resources and guidance, auto-population of data, and real-time collaboration tools for study teams, IRB members, and sponsors/CROs.

2IRB Review Services
CategoryEthics Review Services
Description

Independent ethics review and oversight for clinical research ensuring participant protection and regulatory compliance. Covers Phase I-IV biomedical, biotech, medical device, and noninterventional studies, with full board, expedited, and exempt determinations.

3IBC Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Strategic alliance designed to provide emerging biotech and biopharma sponsors with a modernized, end-to-end experience that makes Real-Time Clinical Trials (RTCTs) a reality. The partnership integrates Univo IRB's efficient IRB model with Validcare's cloud-based SmartSource Clinical Study Platform, providing real-time visibility to high-integrity data via one cloud-based platform. This unified ecosystem connects sponsors, clinical operations, sites, patients, and regulators, accelerating study timelines and reducing costs. Validcare COO Rodney Nuss cited Univo IRB's easy-to-use web-based tools, clear turnaround times, and instant access to dedicated experienced resources.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-28
Description

Partnership to provide essential patient insights that improve clinical trial participation and retention for sponsors and CROs. The collaboration reflects shared belief that patient perspectives should meaningfully inform how clinical research is planned and conducted. The Patient View leads the design and execution of patient insight research using proprietary methodology Walk the Protocol℠ and complementary qualitative approaches. Univo IRB supports coordination and delivery of insights and ethical/regulatory considerations, helping translate patient experience into decision-ready guidance.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

IntegReview IRB is an independent central IRB providing review services for Phase I-IV clinical trials, with experience in pharmaceutical, biotech, and medical device studies. It is a direct competitor to Univo IRB with comparable AAHRPP accreditation and enterprise customer base.

TypeOthers
Description

Validcare is a CRO partner and strategic ally of Univo IRB (June 2026 alliance) providing a cloud-based SmartSource Clinical Study Platform. It is a peer only in the broader clinical research enablement ecosystem, collaborating on real-time clinical trials rather than directly competing for IRB review.

TypeDirect peer
Description

BRANY (Biomedical Research Alliance of New York) is a central IRB serving sponsors, CROs, and academic institutions with IRB review, IBC, and research compliance services. It is a direct competitor to Univo IRB, particularly for studies initiated through academic medical centers and hospital systems.

4Veritas IRB
TypeRegional player
Description

Veritas IRB is a Canadian-based research ethics board providing central IRB/REB services for clinical research in Canada. It is a regional peer to Univo IRB's Canadian REB service, competing for North American clinical trial review mandates.

TypeDirect peer
Description

Sterling IRB is an AAHRPP-accredited central IRB providing independent ethics review for clinical trials across pharmaceutical, biotech, and medical device studies. It is a direct competitor to Univo IRB in the same central IRB service category with similar customer segments.

TypeDirect peer
Description

Copernicus Group IRB (CGIRB) is an AAHRPP-accredited central IRB review provider serving biomedical and behavioral research sponsors. It competes directly with Univo IRB for central IRB mandates across all therapeutic areas and phases.

TypeDirect peer
Description

Multiple members of Univo IRB's leadership team previously held senior roles at Schulman IRB, which is now part of Advarra. Schulman is referenced as a direct competitor predecessor entity for institutional IRB review across all phases.

TypeDirect peer
Description

Advarra is the largest central IRB in North America, formed from the merger of Schulman IRB, Chesapeake IRB, and Quorum Review. It directly competes with Univo IRB on multi-site Phase I-IV central IRB review, IBC services, and technology-enabled review workflows, serving the same sponsor, CRO, and academic medical center customers.

TypeDirect peer
Description

WCG (formerly Western IRB) is one of the largest central IRBs globally, offering IRB review, IBC services, and a suite of clinical research technologies. It competes directly with Univo IRB for institutional and sponsor central IRB mandates across all phases and study types.

TypeEmerging player
Description

Large academic medical centers (Mayo Clinic, Johns Hopkins, etc.) operate local IRBs and increasingly act as single IRBs of record for multi-site NIH-funded trials. They are an emerging competitive category for sponsor-initiated research, intersecting with Univo IRB's institutional services segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Univo IRB

Institutional Review Board Servicesunivo-group.com

Univo IRB provides independent central ethics review and oversight for clinical research, serving pharmaceutical sponsors, CROs, academic medical centers, research sites, and individual investigators via its proprietary AI-enabled OneVerse platform.

What Univo IRB does

Univo IRB is a U.S.-based central Institutional Review Board (IRB) provider offering independent ethics review and oversight for clinical research studies spanning Phase I-IV biomedical, biotech, medical device, and noninterventional trials. Founded in 2016 as Principal IRB, rebranded in February 2024, and acquired by healthcare-focused private equity firm QHP Capital in 2023, the company is headquartered in Raleigh, North Carolina, and operates primarily across North America, having launched Canadian Research Ethics Board (REB) review services in September 2024. Univo sells centralized study review services to sponsors, contract research organizations (CROs), academic medical centers, hospitals, research sites, and individual investigators under a quote-based professional-services model with multi-year contract support.

The company's core product is OneVerse®, a proprietary purpose-built electronic IRB submission portal that combines electronic submissions, real-time status tracking, dynamic form generation, document collaboration, and—since September 2025—AI-powered workflow automation covering process automation, predictive review-timeline forecasting, and knowledge retrieval. Adjacent revenue streams include Institutional Biosafety Committee (IBC) services, Human Research Protection (HRP) and Good Clinical Practice (GCP) training, and clinical research consulting on AI governance, auditing, study design, and voice-of-patient services. Pricing is not publicly disclosed; customers engage Univo through dedicated IRB professionals supplemented by the OneVerse self-serve portal and direct sales motion.

Univo differentiates through AAHRPP accreditation (held since 2020, reaccredited for five years in September 2023), FDA registration (IORG0009156 / IRB00010912) with a January 2026 inspection completed with zero findings, a leadership team composed of veterans from Independent IRB, Schulman, and Advarra, and strategic alliances with Validcare (June 2026, integrated CRO+IRB platform for emerging biotech) and The Patient View (January 2026, patient-insight analytics). Distribution relies on direct enterprise sales, industry-conference presence (SCOPE, ADLM, PRIM&R, ClinOps at Sea, SCRS Global), and a content-and-podcast-driven thought-leadership channel.

Univo IRB firmographics

Firmographics
Name
Univo IRB
Legal name
Univo LLC
Website
https://univo-group.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Univo IRB provides independent central ethics review and oversight for clinical research, serving pharmaceutical sponsors, CROs, academic medical centers, research sites, and individual investigators via its proprietary AI-enabled OneVerse platform.
Ownership category
akta.pro rank

Univo IRB industry classification

Industry
Product category
Institutional Review Board Services
NAICS
Other Scientific and Technical Consulting Services (54169), Educational Support Services (611710)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAJACAG
Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYEDADAKAH
Research Administration & Compliance (Sponsored Programs, IRB/REB)
Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)

Keywords

  • Institutional review board
  • Ethics review services
  • Clinical research oversight
  • Biosafety committee review
  • Human research protection

Where Univo IRB is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Univo IRB business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. IRB Review Services: Core revenue from providing independent ethics review and oversight for clinical research including Phase I-IV biomedical, biotech, medical device, and noninterventional studies. Revenue is generated through study review fees, with dedicated professionals assigned to each client.
  2. Institutional Biosafety Committee (IBC) Services: Support services for institutional biosafety committee approval as part of comprehensive regulatory oversight.
  3. Training Services: Human research protection (HRP) and good clinical practice (GCP) training services for research teams, administrators, and compliance staff. Includes accredited and certified training modules.
  4. Clinical Research Consulting: Consulting services including strategic guidance for research administration, AI governance, auditing and compliance, research study design, temporary staffing solutions, and voice of patient services.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing - contact for fee schedule

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Univo IRB product offering

Product offering

Core offering

Univo IRB provides independent Institutional Review Board (IRB) ethics review and oversight services for clinical research, covering Phase I-IV biomedical, biotech, medical device, and noninterventional studies. Core service delivery is supported by OneVerse®, a proprietary AI-enabled electronic IRB submission and workflow platform. Surrounding the platform, Univo IRB offers Institutional Biosafety Committee (IBC) approval support, Human Research Protection (HRP) and Good Clinical Practice (GCP) training, and clinical research consulting including AI governance, auditing, staffing, and patient insight services.

Product overview

Univo IRB operates as a next-generation Institutional Review Board provider offering a unified portfolio centered on its proprietary OneVerse® technology platform. OneVerse serves as the core electronic IRB platform enabling AI-powered workflow automation, electronic submissions, and real-time collaboration. Surrounding this platform, Univo provides complementary service modules including IRB Review Services (Phase I-IV biomedical, device, and behavioral research), IBC Services for biosafety committee approval, Training Services (HRP/GCP certification), and Clinical Research Consulting Services (strategic guidance, AI governance, auditing, and voice-of-patient support). The company emphasizes an integrated approach where technology and human expertise combine to deliver agile, patient-centered ethics review.

Differentiator

Problem solved

Functional benefit

Brands

  • OneVerse: AI-enabled, purpose-built electronic IRB submission portal and platform for central IRB review, enabling study submission, secure document sharing, and direct communication across research study stakeholders.

Products and services

  • OneVerse® Platform Proprietary purpose-built electronic IRB platform that modernizes IRB submission, review, and oversight. OneVerse provides AI-powered workflow automation, dynamic form generation, searchable submission tracking, live chat support, 24/7 access to resources and guidance, auto-population of data, and real-time collaboration tools for study teams, IRB members, and sponsors/CROs.
  • IRB Review Services Independent ethics review and oversight for clinical research ensuring participant protection and regulatory compliance. Covers Phase I-IV biomedical, biotech, medical device, and noninterventional studies, with full board, expedited, and exempt determinations.
  • IBC Services

Quantifiable outcome

  • Up to 60% reduction in average turnaround times reported by early adopters
  • +4 more outcomes

Companies that use Univo IRB

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Univo IRB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature2 records

Univo IRB partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • ValidcarecoreStrategic or Co-development Partner · 2 June 2026Strategic alliance designed to provide emerging biotech and biopharma sponsors with a modernized, end-to-end experience that makes Real-Time Clinical Trials (RTCTs) a reality. The partnership integrates Univo IRB's efficient IRB model with Validcare's cloud-based SmartSource Clinical Study Platform, providing real-time visibility to high-integrity data via one cloud-based platform. This unified ecosystem connects sponsors, clinical operations, sites, patients, and regulators, accelerating study timelines and reducing costs. Validcare COO Rodney Nuss cited Univo IRB's easy-to-use web-based tools, clear turnaround times, and instant access to dedicated experienced resources.
  • The Patient ViewcoreStrategic or Co-development Partner · 28 January 2026Partnership to provide essential patient insights that improve clinical trial participation and retention for sponsors and CROs. The collaboration reflects shared belief that patient perspectives should meaningfully inform how clinical research is planned and conducted. The Patient View leads the design and execution of patient insight research using proprietary methodology Walk the Protocol℠ and complementary qualitative approaches. Univo IRB supports coordination and delivery of insights and ethical/regulatory considerations, helping translate patient experience into decision-ready guidance.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Univo IRB competitors and assessment

Company assessment

Direct peers

  • IntegReview IRB: IntegReview IRB is an independent central IRB providing review services for Phase I-IV clinical trials, with experience in pharmaceutical, biotech, and medical device studies. It is a direct competitor to Univo IRB with comparable AAHRPP accreditation and enterprise customer base.
  • BRANY: BRANY (Biomedical Research Alliance of New York) is a central IRB serving sponsors, CROs, and academic institutions with IRB review, IBC, and research compliance services. It is a direct competitor to Univo IRB, particularly for studies initiated through academic medical centers and hospital systems.
  • Sterling IRB: Sterling IRB is an AAHRPP-accredited central IRB providing independent ethics review for clinical trials across pharmaceutical, biotech, and medical device studies. It is a direct competitor to Univo IRB in the same central IRB service category with similar customer segments.
  • Copernicus Group IRB: Copernicus Group IRB (CGIRB) is an AAHRPP-accredited central IRB review provider serving biomedical and behavioral research sponsors. It competes directly with Univo IRB for central IRB mandates across all therapeutic areas and phases.
  • Advarra (formerly Schulman IRB): Multiple members of Univo IRB's leadership team previously held senior roles at Schulman IRB, which is now part of Advarra. Schulman is referenced as a direct competitor predecessor entity for institutional IRB review across all phases.
  • Advarra: Advarra is the largest central IRB in North America, formed from the merger of Schulman IRB, Chesapeake IRB, and Quorum Review. It directly competes with Univo IRB on multi-site Phase I-IV central IRB review, IBC services, and technology-enabled review workflows, serving the same sponsor, CRO, and academic medical center customers.
  • WCG IRB: WCG (formerly Western IRB) is one of the largest central IRBs globally, offering IRB review, IBC services, and a suite of clinical research technologies. It competes directly with Univo IRB for institutional and sponsor central IRB mandates across all phases and study types.

Others

  • Validcare: Validcare is a CRO partner and strategic ally of Univo IRB (June 2026 alliance) providing a cloud-based SmartSource Clinical Study Platform. It is a peer only in the broader clinical research enablement ecosystem, collaborating on real-time clinical trials rather than directly competing for IRB review.

Regional players

  • Veritas IRB: Veritas IRB is a Canadian-based research ethics board providing central IRB/REB services for clinical research in Canada. It is a regional peer to Univo IRB's Canadian REB service, competing for North American clinical trial review mandates.

Emerging players

  • Mayo Clinic IRB (Academic Medical Center IRBs): Large academic medical centers (Mayo Clinic, Johns Hopkins, etc.) operate local IRBs and increasingly act as single IRBs of record for multi-site NIH-funded trials. They are an emerging competitive category for sponsor-initiated research, intersecting with Univo IRB's institutional services segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Univo IRB social profiles

Digital presence

Univo IRB compliance and trust

Trust signal

Compliance2 records

Univo IRB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Univo IRB leadership team

Management profile

Number of profiles

Profiles7 records

Univo IRB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Univo IRB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Univo IRB

What does Univo IRB do?

Univo IRB provides independent Institutional Review Board (IRB) ethics review and oversight services for clinical research, covering Phase I-IV biomedical, biotech, medical device, and noninterventional studies. Core service delivery is supported by OneVerse®, a proprietary AI-enabled electronic IRB submission and workflow platform. Surrounding the platform, Univo IRB offers Institutional Biosafety Committee (IBC) approval support, Human Research Protection (HRP) and Good Clinical Practice (GCP) training, and clinical research consulting including AI governance, auditing, staffing, and patient insight services.

Is Univo IRB a public or private company?

Univo IRB is a private company. It is classified as private equity controlled and is currently operating.

When was Univo IRB founded?

Univo IRB was founded in 2016. It employs 51 to 100 people.

Where is Univo IRB based?

Univo IRB is headquartered in Raleigh, United States, in the North America region.

How does Univo IRB make money?

Four revenue lines are on record. IRB Review Services are the primary driver. The others are institutional Biosafety Committee (IBC) Services, training Services and clinical Research Consulting.

Who are Univo IRB's main competitors?

Direct peers on record are IntegReview IRB, BRANY, Sterling IRB, Copernicus Group IRB, Advarra (formerly Schulman IRB), Advarra and WCG IRB. Validcare is listed as an others. Veritas IRB is listed as a regional player. Mayo Clinic IRB (Academic Medical Center IRBs) is listed as an emerging player.

Does Univo IRB have an API?

No public API is recorded for Univo IRB.

What industry is Univo IRB in?

Univo IRB's product category is Institutional Review Board Services. Its primary akta.pro industry code is HLAJACAG, Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight), with a secondary code of EDADAKAH, Research Administration & Compliance (Sponsored Programs, IRB/REB). Its NAICS code is 54169 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals